Dalpiciclib Plus Camrelizumab for HCC Patients Who Have Previously Received ICI Treatment
Clinical trial NCT07238881 · RECRUITING
Trial details
- NCT number
- NCT07238881
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-05
- Primary completion
- 2026-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.